LOTUSNCT07611708
Lubricin-inspired Osteoarthritis Treatment: a Unique Solution
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary completion moved at least 8 months later.
See at-risk trials from Pleryon Therapeutics (Hangzhou) Limited
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 2 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Jun 2027 to Mar 2028 Show 6 more changesShow less
- Recruitment opened
- Eligibility criteria expanded, about 32 words
- Study completion pushed from Dec 2027 to Jun 2028
- Start date changed from estimate of Aug 2026 to Nov 1, 2026
- Site details revised
- Publications: details revised at 1 of 1 entry
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Number of adverse events
Timeframe: from the day receiving study intervention (day 0) to 12 weeks after study intervention
Arms and interventions
Received ABR1Experimental
Received a single dose of ABR1
Devices: ABR1
Sites
1 site in 1 country
- Royal North Shore HospitalSydney, New South Wales, Australia